×
0.0566037735849057 0.0566037735849057 0.0566037735849057 0.0566037735849057 0.0566037735849057 0.0566037735849055 0.0373584905660376 0.0373584905660376
Stockreport

Zosano Pharma Announces Notice of Allowance for a U.S. Patent Application Covering M207 as an Acute Treatment for Migraine

ZOSANA PHARMA CORP (ZSAN)  More Company Research Source: GlobeNewswire
Last zosana pharma corp earnings: 11/9 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.zosanopharma.com
PDF FREMONT, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ:ZSAN) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to subjects using its proprietary Adhesive Dermally-Applied Microarray (“ADAM”) technology, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application titled “Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines”.  In February 2017, Zosano reported positive pivotal data from our Zotrip Phase 2/3 trial, in which subjects treated with the 3.8mg dose of M207 achieved statistical significance on the co-primary endpoints. This newly-allowed patent application contains claims generated from formulation, preclinical and clinical studies, and highlights the unique aspects of the Zosano technologies and their applicability for treatment of migraine. [Read more]

IMPACT SNAPSHOT EVENT TIME: ZSAN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ZSAN alerts
from News Quantified